EW:NYSE
Edwards Lifesciences Corp
85,21 $
arrow_upward
+1,10%(+0,93) 1D
85,21 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 қаз., 16:00:05 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
84,60 $
High
85,34 $
Low
83,22 $
Mkt. cap
49,12 млрд
Avg. vol.
3,43 млн
Volume
3,89 млн
P/E ratio
49,30
52-wk high
96,29 $
52-wk low
72,30 $
EPS
1,73 $
Beta
0,87
Shares outstanding
576,40 млн
No. of employees
16 мың
Open
84,60 $
High
85,34 $
Low
83,22 $
Mkt. cap
49,12 млрд
Avg. vol.
3,43 млн
Volume
3,89 млн
P/E ratio
49,30
52-wk high
96,29 $
52-wk low
72,30 $
EPS
1,73 $
Beta
0,87
Shares outstanding
576,40 млн
No. of employees
16 мың
News stories
From web sources and news partners
News Corp
·
1 күн бұрын
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
MarketBeat
·
2 күн бұрын
Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
Investing.com Australia
·
2 күн бұрын
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations By Investing.com
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 мың
Founded1958
HeadquartersИрвайн, Калифорния, Америка Құрама Штаттары
SectorMedical device
Websiteedwards.com